Resverlogix Corp. (TSE:RVX – Get Free Report)’s share price crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$0.05 and traded as low as C$0.05. Resverlogix shares last traded at C$0.05, with a volume of 3,000 shares.
Resverlogix Trading Down 10.0 %
The stock has a market capitalization of C$8.91 million, a PE ratio of -2.23 and a beta of 0.71. The firm has a 50 day moving average price of C$0.05 and a 200 day moving average price of C$0.06. The company has a quick ratio of 0.04, a current ratio of 0.13 and a debt-to-equity ratio of -10.95.
Resverlogix Company Profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Featured Stories
- Five stocks we like better than Resverlogix
- What is the Nikkei 225 index?
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- What is Put Option Volume?
- DuPont’s Electronics Spinoff: The Start of Something Big
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
